197 related articles for article (PubMed ID: 11259649)
1. Suppression of ras-mediated transformation and inhibition of tumor growth and angiogenesis by anthrax lethal factor, a proteolytic inhibitor of multiple MEK pathways.
Duesbery NS; Resau J; Webb CP; Koochekpour S; Koo HM; Leppla SH; Vande Woude GF
Proc Natl Acad Sci U S A; 2001 Mar; 98(7):4089-94. PubMed ID: 11259649
[TBL] [Abstract][Full Text] [Related]
2. Anthrax lethal toxin inhibits growth of and vascular endothelial growth factor release from endothelial cells expressing the human herpes virus 8 viral G protein coupled receptor.
Depeille P; Young JJ; Boguslawski EA; Berghuis BD; Kort EJ; Resau JH; Frankel AE; Duesbery NS
Clin Cancer Res; 2007 Oct; 13(19):5926-34. PubMed ID: 17908989
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of MAPK kinase signaling pathways suppressed renal cell carcinoma growth and angiogenesis in vivo.
Huang D; Ding Y; Luo WM; Bender S; Qian CN; Kort E; Zhang ZF; VandenBeldt K; Duesbery NS; Resau JH; Teh BT
Cancer Res; 2008 Jan; 68(1):81-8. PubMed ID: 18172299
[TBL] [Abstract][Full Text] [Related]
4. Apoptosis and melanogenesis in human melanoma cells induced by anthrax lethal factor inactivation of mitogen-activated protein kinase kinase.
Koo HM; VanBrocklin M; McWilliams MJ; Leppla SH; Duesbery NS; Vande Woude GF
Proc Natl Acad Sci U S A; 2002 Mar; 99(5):3052-7. PubMed ID: 11867750
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of tumor angiogenesis by the matrix metalloproteinase-activated anthrax lethal toxin in an orthotopic model of anaplastic thyroid carcinoma.
Alfano RW; Leppla SH; Liu S; Bugge TH; Ortiz JM; Lairmore TC; Duesbery NS; Mitchell IC; Nwariaku F; Frankel AE
Mol Cancer Ther; 2010 Jan; 9(1):190-201. PubMed ID: 20053778
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinase-activated anthrax lethal toxin inhibits endothelial invasion and neovasculature formation during in vitro morphogenesis.
Alfano RW; Leppla SH; Liu S; Bugge TH; Meininger CJ; Lairmore TC; Mulne AF; Davis SH; Duesbery NS; Frankel AE
Mol Cancer Res; 2009 Apr; 7(4):452-61. PubMed ID: 19372576
[TBL] [Abstract][Full Text] [Related]
7. Biological and biochemical characterization of anthrax lethal factor, a proteolytic inhibitor of MEK signaling pathways.
Bromberg-White JL; Duesbery NS
Methods Enzymol; 2008; 438():355-65. PubMed ID: 18413261
[TBL] [Abstract][Full Text] [Related]
8. Anthrax lethal toxin disrupts the endothelial permeability barrier through blocking p38 signaling.
Liu T; Milia E; Warburton RR; Hill NS; Gaestel M; Kayyali US
J Cell Physiol; 2012 Apr; 227(4):1438-45. PubMed ID: 21618534
[TBL] [Abstract][Full Text] [Related]
9. Effects of anthrax lethal toxin on human primary keratinocytes.
Koçer SS; Matic M; Ingrassia M; Walker SG; Roemer E; Licul G; Simon SR
J Appl Microbiol; 2008 Dec; 105(6):1756-67. PubMed ID: 19120626
[TBL] [Abstract][Full Text] [Related]
10. Systemic anthrax lethal toxin therapy produces regressions of subcutaneous human melanoma tumors in athymic nude mice.
Abi-Habib RJ; Singh R; Leppla SH; Greene JJ; Ding Y; Berghuis B; Duesbery NS; Frankel AE
Clin Cancer Res; 2006 Dec; 12(24):7437-43. PubMed ID: 17189417
[TBL] [Abstract][Full Text] [Related]
11. Anthrax lethal factor causes proteolytic inactivation of mitogen-activated protein kinase kinase.
Duesbery NS; Vande Woude GF
J Appl Microbiol; 1999 Aug; 87(2):289-93. PubMed ID: 10475971
[TBL] [Abstract][Full Text] [Related]
12. Radicicol suppresses transformation and restores tropomyosin-2 expression in both ras- and MEK-transformed cells without inhibiting the Raf/MEK/ERK signaling cascade.
Kim PN; Jonasch E; Mosterman BC; Mier JW; Janssen RA
Cell Growth Differ; 2001 Nov; 12(11):543-50. PubMed ID: 11714635
[TBL] [Abstract][Full Text] [Related]
13. Consequences and utility of the zinc-dependent metalloprotease activity of anthrax lethal toxin.
Bromberg-White J; Lee CS; Duesbery N
Toxins (Basel); 2010 May; 2(5):1038-53. PubMed ID: 22069624
[TBL] [Abstract][Full Text] [Related]
14. Persistent inhibition of oxygen-induced retinal neovascularization by anthrax lethal toxin.
Bromberg-White JL; Boguslawski E; Hekman D; Kort E; Duesbery NS
Invest Ophthalmol Vis Sci; 2011 Nov; 52(12):8979-92. PubMed ID: 21989728
[TBL] [Abstract][Full Text] [Related]
15. Mitogen-activated protein kinase kinase signaling promotes growth and vascularization of fibrosarcoma.
Ding Y; Boguslawski EA; Berghuis BD; Young JJ; Zhang Z; Hardy K; Furge K; Kort E; Frankel AE; Hay RV; Resau JH; Duesbery NS
Mol Cancer Ther; 2008 Mar; 7(3):648-58. PubMed ID: 18319331
[TBL] [Abstract][Full Text] [Related]
16. Perturbation of mouse retinal vascular morphogenesis by anthrax lethal toxin.
Bromberg-White JL; Boguslawski E; Duesbery NS
PLoS One; 2009 Sep; 4(9):e6956. PubMed ID: 19750016
[TBL] [Abstract][Full Text] [Related]
17. Critical role of the phosphatidylinositol 3-kinase/Akt/glycogen synthase kinase-3 signaling pathway in recovery from anthrax lethal toxin-induced cell cycle arrest and MEK cleavage in macrophages.
Ha SD; Ng D; Pelech SL; Kim SO
J Biol Chem; 2007 Dec; 282(50):36230-9. PubMed ID: 17951252
[TBL] [Abstract][Full Text] [Related]
18. Potent inhibition of tumor angiogenesis by the matrix metalloproteinase-activated anthrax lethal toxin: implications for broad anti-tumor efficacy.
Alfano RW; Leppla SH; Liu S; Bugge TH; Duesbery NS; Frankel AE
Cell Cycle; 2008 Mar; 7(6):745-9. PubMed ID: 18245947
[TBL] [Abstract][Full Text] [Related]
19. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.
Rusyn EV; Reynolds ER; Shao H; Grana TM; Chan TO; Andres DA; Cox AD
Oncogene; 2000 Sep; 19(41):4685-94. PubMed ID: 11032018
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of Interleukin 1β (IL-1β) Expression by Anthrax Lethal Toxin (LeTx) Is Reversed by Histone Deacetylase 8 (HDAC8) Inhibition in Murine Macrophages.
Ha SD; Reid C; Meshkibaf S; Kim SO
J Biol Chem; 2016 Apr; 291(16):8745-55. PubMed ID: 26912657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
